9月25日 - ** 衍生品交易所运营商 CME 集团 CME.O 股价盘前上涨 1%，至 267 美元
** 花旗将CME的评级从 "持有 "上调至 "买入"，理由是未来将出现催化剂
* (link) * 花旗将CME的评级从 "持有 "调高至 "买入"，理由是未来将出现催化剂。
** 认为 CME 与 FanDuel 的合资企业 (link) 应有助于该公司扩大其零售业务
** 18家券商中有6家对该股的评级为 "买入 "或更高，9家为 "持有"，3家为 "卖出"；PT中位数为285美元--数据由LSEG编制
** 截至上次收盘，CME股价年累计上涨14
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.